Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma
Cancer · 2024
DOI: 10.1002/cncr.35196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Marija Kacar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Radiotherapy Dosage, Bone Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Local control for patients with Ewing sarcoma (EWS) who present with large tumors are suboptimal when treated with standard radiation therapy (RT) doses of 54–55.8 Gy. The purpose of this study is to determine local control and toxicity of dose‐escalated RT for tumors ≥8 cm (greatest diameter at diagnosis) in pediatric and young adult patients with EWS.
Methods
Eligible patients ≤30 years old with newly diagnosed EWS ≥8 cm treated with definitive conformal or intensity modulated photon, or proton radiation therapy techniques were included. All patients in the study received dose‐escalated RT doses. Outcomes included overall survival (OS), event‐free survival (EFS), local failure rates, and toxicity.
Results
Thirty‐two patients were included, 20 patients presented with metastatic disease and 12 patients with localized disease. The median RT dose was 64.8 Gy (range, 59.4–69.4 Gy) with variability of doses to protect normal surrounding tissues. All patients received systemic chemotherapy. The 5‐year OS and EFS for the cohort was 64.2% and 42%, respectively. The 5‐year cumulative incidence of local failure was 6.6%. There were two combined local and distant failures with no isolated local failures. Twenty‐nine patients experienced short term toxicity, 90% of those being radiation dermatitis. Twenty‐seven patients experienced long‐term toxicity, with only one experiencing grade 4 toxicity, a secondary malignancy after therapy.
Conclusion
This study demonstrates that definitive RT for pediatric and young adult patients with EWS ≥8 cm provides high rates of local control, while maintaining a tolerable toxicity profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Pediatrics, UT Southwestern Medical Center Dallas, Dallas, Texas, USA.
- Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID-Profile: Marija Kacar, Margaret B Nagel, John T Lucas, M Beth McCarville, Alberto S Pappo, Matthew J Krasin
Förderung
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Kacar, M., Nagel, M. B., Liang, J., Li, Y., Neel, M. D., Lucas, J. T., McCarville, M. B., Santiago, T., Pappo, A. S., & Krasin, M. J. (2024). Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma. Cancer. https://doi.org/10.1002/cncr.35196
Vancouver
Kacar M, Nagel MB, Liang J, Li Y, Neel MD, Lucas JT, et al. Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma. Cancer. 2024. doi:10.1002/cncr.35196
BibTeX
@article{Kacar2024,
author = {Kacar, Marija and Nagel, Margaret B and Liang, Jia and Li, Yimei and Neel, Michael D and Lucas, John T and McCarville, M Beth and Santiago, Teresa and Pappo, Alberto S and Krasin, Matthew J},
title = {Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35196}
}
EUVIMED